首页> 外国专利> APPLICATION OF A-SCAN ULTRASOUND IN DEVELOPMENT OF MYOPIA-RELATED DRUG

APPLICATION OF A-SCAN ULTRASOUND IN DEVELOPMENT OF MYOPIA-RELATED DRUG

机译:A型超声在近视相关药物研制中的应用

摘要

Disclosed is a method for verifying a relaxation effect of a muscarinic receptor antagonist on a ciliary smooth muscle by measuring a change in the thickness of the lens of a non-human primate (monkey) using an A-scan ultrasound technique. The method can be used to measure effects of different concentrations of a drug under test on lens thickness, understand a dose-efficacy relationship between the drug under test and lens thickness, infer an effect of the drug on refractive accommodation, measure an effective dose, and quickly and effectively guide preclinical development of new drugs for the prevention and treatment of juvenile myopia. The method of the present invention is simple and technically stable, and has good repeatability, and does not cause tissue trauma in animals or damage to whole-body health. Experimental data obtained from monkeys (animals most similar to humans) has significant value for guiding clinical trials compared to other animals, thereby providing important translational medical information for the development of innovative drugs.
机译:本发明公开了一种通过使用a扫描超声技术测量非人灵长类动物(猴子)晶状体厚度的变化来验证毒蕈碱受体拮抗剂对睫状肌平滑肌的松弛作用的方法。该方法可用于测量受试药物不同浓度对晶状体厚度的影响,了解受试药物与晶状体厚度之间的剂量-效应关系,推断药物对屈光调节的影响,测量有效剂量,快速有效地指导青少年近视防治新药的临床前开发。本发明方法简单,技术稳定,重复性好,不会对动物造成组织损伤或损害全身健康。与其他动物相比,从猴子(与人类最相似的动物)获得的实验数据对于指导临床试验具有重要价值,从而为创新药物的开发提供重要的转化医学信息。

著录项

  • 公开/公告号WO2022083034A1

    专利类型

  • 公开/公告日2022-04-28

    原文格式PDF

  • 申请/专利权人 JOINN LABORATORIES (SUZHOU) INC.;

    申请/专利号WO2021CN75512

  • 发明设计人 LI HEPING;LIAO QIN;CAI KEYANG;

    申请日2021-02-05

  • 分类号A61K49;A61B8/10;

  • 国家 CN

  • 入库时间 2022-08-25 00:47:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号